Trials / Unknown
UnknownNCT05834231
Efficacy of Memantine in Prevention of Oxaliplatin-induced Peripheral Neurotoxicity
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Mansoura University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Memantine is a drug for the management of Alzheimer's Disease (AD) due to its promising neuroprotective properties. We hypothesize that Memantine possesses a beneficial role against chemotherapy-induced neuronal damages.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Memantine | oral |
| DRUG | Placebo | oral |
Timeline
- Start date
- 2023-08-01
- Primary completion
- 2024-03-01
- Completion
- 2024-10-01
- First posted
- 2023-04-28
- Last updated
- 2023-04-28
Source: ClinicalTrials.gov record NCT05834231. Inclusion in this directory is not an endorsement.